Ning Ren - and Institute of Fudan-Minhang Academic Health System, Fudan University

基本信息

浏览量：130

职业迁徙

个人简介

Ning Ren is the undergraduate of Fudan University, he will receive a B.Sc. in Computer Science from Fudan University of Shanghai, China in 2010. He is visiting Microsoft Research Asia as an intern in 2008 and 2009. His research interests include peer-to-peer network, data mining of program.

研究兴趣

论文共 177 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Association Between KLF4 As a Tumor Suppressor and the Prognosis of Hepatocellular Carcinoma after Curative Resection

Min Xue, Chenhao Zhou,Yan Zheng,Ziping Zhang,Shun Wang,Yan Fu,Manar Atyah,Xiaolong Xue,Le Zhu,Qiongzhu Dong,Huliang Jia,Ning Ren,Ruolei Hu

Aging（2025）

引用7浏览0WOS引用

Denoised Recurrence Label-Based Deep Learning for Prediction of Postoperative Recurrence Risk and Sorafenib Response in HCC

Yixin Li,Ji Xiong,Zhiqiu Hu,Qimeng Chang,Ning Ren,Fan Zhong,Qiongzhu Dong,Lei Liu

BMC Medicineno. 1 (2025): 1-17

引用0浏览0WOS引用

LCAT Deficiency Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance by Promoting Triglyceride Catabolism and Fatty Acid Oxidation

Min Xu,Peiyi Xie, Shaoqing Liu, Xukang Gao, Shiguang Yang,Zhiqiu Hu, Yue Zhao, Yong Yi,Qiongzhu Dong, Christiane Bruns,Xiaoni Kong,Mien-Chie Hung,Ning Ren,Chenhao Zhou

CANCER LETTERS (2025)

引用0浏览0WOS引用

The Role of Post-Translational Modifications in Necroptosis

Hao Xiao, Zeping Han,Min Xu, Xukang Gao,Shuangjian Qiu,Ning Ren, Yong Yi, Chenhao Zhou

Biomoleculesno. 4 (2025)

引用0浏览0WOS引用

In-Depth Proteomic Analysis of Tissue Interstitial Fluid Reveals Biomarker Candidates Related to Varying Differentiation Statuses in Gastric Adenocarcinoma

Juxiang Zhang, An Xiong, Yuanyuan Yang,Yiou Cao, Mengxuan Yang,Chang Su, Ming Lei,Yi Chen, Xiaodong Shen, Puhua Wang, Chencheng Shi, Rongjian Zhou,Ning Ren, Hongwen Zhu,Chunyan Yuan,Shaoqun Liu,Fei Teng

JOURNAL OF PROTEOME RESEARCH (2025)

引用0浏览0WOS引用

Supplementary Figure S2 from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy